Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways

Yohannes T. Ghebre, Odutayo O. Odunuga, Kristen Janse, Girish J. Kotwal

Research output: Contribution to journalArticle

10 Scopus citations

Fingerprint Dive into the research topics of 'Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways'. Together they form a unique fingerprint.

Medicine & Life Sciences

Arts & Humanities

Chemical Compounds